© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
A look back at some of the major news stories we covered this year.
The new therapies include immune checkpoint inhibitors; therapeutic vaccines; CAR T-cell therapies; and “conjugate” drugs.
New tech enables deep dive into mysterious results, sets stage for future improvements.
New treatment approaches target tumors with shared characteristics, regardless of where they appear in the body.
Opdivo will be used to treat hepatocellular carcinoma, which can be caused by hepatitis B or C.
Imfinzi tripled progression-free survival in previously treated patients with inoperable lung cancer.
Kymriah, a novel CAR-T therapy, helps the immune system recognize and fight cancer.
Canakinumab was associated with lower lung cancer risk in a large cardiovascular study.
Cancer and HIV are invaders that the immune system fails to detect, and the similarities don’t end there.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
